Abbott launches residual cancer test
Abbott has launched an updated version of its Oncodetect blood test, which helps clinicians determine whether cancer remains in patients with solid tumors during or after treatment. The test can detect tumor DNA at levels 30 times lower than its predecessor, according to an Oct. 26 news release from the company. It is now available […] The post Abbott launches residual cancer test appeared first on Becker's Hospital Review | Healthcare News & Analysis.
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.